Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review
Keyword(s):
2019 ◽
Vol 18
(7)
◽
pp. 603-610
◽
2018 ◽
Vol 50
(11)
◽
pp. 1105-1114
◽
2018 ◽
Vol 50
(2)
◽
pp. 113-123
◽
2015 ◽
Vol 5
(11)
◽
pp. 1396-1402
1998 ◽
Vol 139
(5)
◽
pp. 924-925
◽
Keyword(s):
1997 ◽
Vol 96
(2)
◽
pp. 427-428
◽
Keyword(s):
2001 ◽
Vol 8
(1)
◽
pp. 41-47
◽